| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| N,N′-Diacetyl-L-cystine |
N，N'-二乙?；?L-胱氨酸 |
5545-17-5 |
詳細(xì)
|
| NESS 0327 |
NESS 0327,CB1拮抗劑 |
494844-07-4 |
詳細(xì)
|
| FBPase-1 inhibitor |
FBPase-1抑制劑 |
883973-99-7 |
詳細(xì)
|
| Ethyl acetoacetate sodium salt |
乙酰乙酸乙酯鈉鹽 |
20412-62-8 |
詳細(xì)
|
| Phe-Lys(Trt)-PAB |
|
1116085-99-4 |
詳細(xì)
|
| Methacryloyl chloride |
甲基丙烯酰氯 |
920-46-7 |
詳細(xì)
|
| Tetraethylphosphonium Tetrafluoroborate |
四乙基鏻四氟硼酸鹽 |
665-49-6 |
詳細(xì)
|
| Gold(III) chloride |
氯化金(III) |
13453-07-1 |
詳細(xì)
|
| Fast Red Violet LB Salt |
固紅紫LB鹽 |
32348-81-5 |
詳細(xì)
|
| MELK-8a hydrochloride |
鹽酸MELK-8a |
1922153-17-0 |
詳細(xì)
|
| PF-3450074 |
|
1352879-65-2 |
詳細(xì)
|
| D-I03 |
|
688342-78-1 |
詳細(xì)
|
| SB408124 |
|
288150-92-5 |
詳細(xì)
|
| Limaprost |
利馬前列素 |
74397-12-9 |
詳細(xì)
|
| 9-PAHSA |
|
1481636-31-0 |
詳細(xì)
|
| JNJ-40411813 |
|
1127498-03-6 |
詳細(xì)
|
| (±)-Palmitoylcarnitine chloride |
（±）-棕櫚酰肉堿氯化物 |
6865-14-1 |
詳細(xì)
|
| Ficlatuzumab (anti-HGF) |
|
1174900-84-5 |
詳細(xì)
|
| Poly(ethylene glycol) behenyl ether methacrylate solution |
聚（乙二醇）二十二烷基醚甲基丙烯酸酯溶液 |
125441-87-4 |
詳細(xì)
|
| 2-Amino-5-bromothiazole |
2-氨基-5-溴噻唑 |
3034-22-8 |
詳細(xì)
|
| MS0015203 |
|
73912-52-4 |
詳細(xì)
|
| DWK-1339 |
|
1018946-38-7 |
詳細(xì)
|
| Eriocitrin |
圣草次苷 |
13463-28-0 |
詳細(xì)
|
| Isomangiferin |
異芒果苷 |
24699-16-9 |
詳細(xì)
|
| DS-1001b (DS 1001) |
|
1898207-64-1 |
詳細(xì)
|
| Isopteropodine |
異翅果定堿 |
5171-37-9 |
詳細(xì)
|
| Fantofarone |
芬托法隆 |
114432-13-2 |
詳細(xì)
|
| Sutimlimab (anti-C1s) |
|
2049079-64-1 |
詳細(xì)
|
| AZD7687 |
AZD7687,DGAT1抑制劑 |
1166827-44-6 |
詳細(xì)
|
| 4-Amino-7-(trifluoromethyl)quinoline |
4-氨基-7-(三氟甲基)喹啉 |
243666-11-7 |
詳細(xì)
|
| Tafasitamab (anti-CD19) |
|
1422527-84-1 |
詳細(xì)
|
| (S)-2-(Aminomethyl)pyrrolidine |
(S)-2-(氨甲基)吡咯烷 |
69500-64-7 |
詳細(xì)
|
| (S)-(+)-2-(Anilinomethyl)pyrrolidine |
(S)-(+)-2-(苯胺基甲基)吡咯烷 |
64030-44-0 |
詳細(xì)
|
| Polatuzumab (anti-CD79b) |
|
2279068-37-8 |
詳細(xì)
|
| Ramucirumab (anti-VEGFR2) |
|
947687-13-0 |
詳細(xì)
|
| Tusamitamab (anti-CEACAM5) |
|
2349294-95-5 |
詳細(xì)
|
| TSQ |
|
109628-27-5 |
詳細(xì)
|
| (3S)-(-)-3-Acetamidopyrrolidine |
(3S)-(-)-3-乙酰胺基吡咯烷 |
114636-31-6 |
詳細(xì)
|
| (R)-(+)-Thalidomide |
（R）-（+）-沙利度胺 |
2614-06-4 |
詳細(xì)
|
| Mezagitamab (anti-CD38) |
|
2227490-52-8 |
詳細(xì)
|
| Polyacenaphthylene |
聚苊 |
25036-01-5 |
詳細(xì)
|
| 2-(Aminomethyl)thiazole |
2-噻唑甲胺 |
55661-33-1 |
詳細(xì)
|
| Seltorexant |
|
1293281-49-8 |
詳細(xì)
|
| Rosarin |
|
84954-93-8 |
詳細(xì)
|
| (S)-(-)-3-Aminopyrrolidine |
(S)-(-)-3-氨基吡咯烷 |
128345-57-3 |
詳細(xì)
|
| Rupintrivir |
蘆平曲韋 |
223537-30-2 |
詳細(xì)
|
| Gantenerumab (anti-Amyloid Beta) |
|
1043556-46-2 |
詳細(xì)
|
| 1-(1,8-Dihydroxy-3-methyl-naphthalen-2-yl)-ethanone |
1-（1,8-二羥基-3-甲基萘-2-基）乙酮 |
3785-24-8 |
詳細(xì)
|
| BTdCPU |
|
1257423-87-2 |
詳細(xì)
|
| Cycloguanil Hydrochloride |
環(huán)氯胍鹽酸鹽 |
152-53-4 |
詳細(xì)
|
| CTOP TFA |
|
103429-31-8 |
詳細(xì)
|
| 8-Chloroadenosine |
8-氯腺嘌呤核苷 |
34408-14-5 |
詳細(xì)
|
| Cyanidin 3-O-Rutinoside |
花青素鼠李葡糖苷 |
18719-76-1 |
詳細(xì)
|
| Boc-NH-PEG12-CH2CH2COOH |
|
1415981-79-1 |
詳細(xì)
|
| 2-Chloro-5-hydroxybenzaldehyde |
2-氯-5-羥基苯甲醛 |
7310-94-3 |
詳細(xì)
|
| Copper molybdenum oxide |
銅鉬氧化物 |
13767-34-5 |
詳細(xì)
|
| Bis[(tetrabutylammonium iodide)copper(I) iodide] |
雙[(碘化四丁基銨)碘化銅(I)] |
81412-07-9 |
詳細(xì)
|
| AR-A014418 |
|
487021-52-3 |
詳細(xì)
|
| Actinonin |
放線酰胺素 |
13434-13-4 |
詳細(xì)
|
| D,L-3-Indolylglycine |
D，L-3-吲哚基甘氨酸 |
6747-15-5 |
詳細(xì)
|
| AT-001 |
|
1355612-71-3 |
詳細(xì)
|
| 1-(2,3-Epoxypropyl)-2-nitroimidazole |
1-(2,3-環(huán)氧丙基)-2-硝基咪唑 |
13551-90-1 |
詳細(xì)
|
| Chlorotriethylsilane |
三乙基氯硅烷 |
994-30-9 |
詳細(xì)
|
| 4-Bromo-6-chloro-1H-indole |
4-溴-6-氯-1H-吲哚 |
885519-23-3 |
詳細(xì)
|
| 3,4-Dimethoxythiophenol |
3,4-二甲氧基苯硫酚 |
700-96-9 |
詳細(xì)
|
| AZD3514 |
|
1240299-33-5 |
詳細(xì)
|
| 3-Penten-1-yne (Mixture of isomers) |
3-戊烯-1-炔（異構(gòu)體混合物） |
2206-23-7 |
詳細(xì)
|
| (R)-4-Phenylthiazolidine-2-thione |
(R)-4-苯基噻唑烷-2-硫酮 |
110199-18-3 |
詳細(xì)
|
| 4-(Benzylamino)phenol |
對(duì)芐氨基苯酚 |
103-14-0 |
詳細(xì)
|
| A812511 |
A812511,PKA抑制劑 |
179985-52-5 |
詳細(xì)
|
| 4,4'-Dibromo-2,2'-bis(triisopropylsilyl)-5,5'-bithiazole |
4,4'-二溴-2,2'-雙(三異丙基甲硅烷基)-5,5'-二噻唑 |
1223559-98-5 |
詳細(xì)
|
| Bay 55-9837 TFA |
Bay 55-9837 TFA,VPAC2激動(dòng)劑 |
463930-25-8 |
詳細(xì)
|
| Lithium L-lactate |
L-乳酸鋰 |
27848-80-2 |
詳細(xì)
|
| 5-Bromo-4,6-difluoropyrimidine |
5-溴-4,6-二氟嘧啶 |
946681-88-5 |
詳細(xì)
|
| 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane |
1-(3,4-二氯苯基)-3-氮雜雙環(huán)[3.1.0]己烷 |
66504-40-3 |
詳細(xì)
|
| 9-(2,6-Dimethylphenyl)-10-methylacridinium Perchlorate |
9-(2,6-二甲基苯基)-10-甲基吖啶高氯酸鹽 |
1276539-32-2 |
詳細(xì)
|
| ARN14974 |
|
1644158-57-5 |
詳細(xì)
|
| AMG 337 |
|
1173699-31-4 |
詳細(xì)
|
| BL 1249 |
BL 1249,K2P2.1（TREK-1）和K2P10.1（TREK-2）激活劑 |
18200-13-0 |
詳細(xì)
|
| 3-((3,4-Dimethoxyphenyl)carbamoyl)pyrazine-2-carboxylic acid |
3-((3,4-二甲氧基苯基)氨基甲?；?吡嗪-2-羧酸 |
685117-25-3 |
詳細(xì)
|
| A-674563 |
|
552325-73-2 |
詳細(xì)
|
| Ethanol-13C |
乙醇-13C? |
70753-79-6 |
詳細(xì)
|
| 3-Hydroxyacetaminophen |
3-羥基對(duì)乙酰氨基酚 |
37519-14-5 |
詳細(xì)
|
| Fadrozole hydrochloride |
鹽酸法倔唑 |
102676-31-3 |
詳細(xì)
|
| Cis-4-Phenylcyclohexan-1-ol |
順式-4-苯基環(huán)己烷-1-醇 |
7335-12-8 |
詳細(xì)
|
| 1-Chloro-4-(2-chloroethyl)benzene |
1-氯-4-(2-氯乙基)苯 |
32327-70-1 |
詳細(xì)
|
| 2,5-Dimethoxythiophenol |
2,5-二甲氧基苯硫酚 |
1483-27-8 |
詳細(xì)
|
| 6-Chloro-2-oxo-2H-chromene-3-carboxylic acid |
6-氯-2-氧代-2H-苯并吡喃-3-羧酸 |
883-92-1 |
詳細(xì)
|
| (+)-Alliin |
(+)-蒜氨酸 |
556-27-4 |
詳細(xì)
|
| 1H-Indazole-3-carbaldehyde |
3-醛基吲唑 |
5235-10-9 |
詳細(xì)
|
| Ethyl 2,4-Dihydroxy-6-methylbenzoate |
2,4-二羥基-6-甲基苯甲酸乙酯 |
2524-37-0 |
詳細(xì)
|
| SingaCycle-A2 |
|
1093348-08-3 |
詳細(xì)
|
| Barium trifluoromethanesulfonate |
三氟甲磺酸鋇 |
2794-60-7 |
詳細(xì)
|
| RuCl2[(S)-xylbinap][(S)-daipen] |
|
220114-01-2 |
詳細(xì)
|
| Chondroitin disaccharide δdi-6S sodium salt |
軟骨素二糖δ二-6S鈉鹽 |
136132-72-4 |
詳細(xì)
|
| POL1-IN-1(Compound 3A) |
化合物3A |
1822358-25-7 |
詳細(xì)
|
| C25-140 |
|
1358099-18-9 |
詳細(xì)
|
| Urea-13C |
尿素-13C |
58069-82-2 |
詳細(xì)
|
| XP-59 |
|
890402-73-0 |
詳細(xì)
|
| (W) Phenyldichlorosilane |
苯基二氯硅烷 |
1631-84-1 |
詳細(xì)
|